171 related articles for article (PubMed ID: 34979986)
21. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
22. Decreased serum level of thioredoxin 1 in female patients with pneumonia and its combinational use with haptoglobin for the specific diagnoses of pneumonia and lung cancer.
Cha MK; Kim IH
Pneumonia (Nathan); 2015; 6():18-25. PubMed ID: 31641575
[TBL] [Abstract][Full Text] [Related]
23. A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years.
Lourenco AP; Benson KL; Henderson MC; Silver M; Letsios E; Tran Q; Gordon KJ; Borman S; Corn C; Mulpuri R; Smith W; Alpers J; Costantini C; Rohatgi N; Yang R; Haythem A; Biren S; Morris M; Kass F; Reese DE
Clin Breast Cancer; 2017 Nov; 17(7):516-525.e6. PubMed ID: 28624156
[TBL] [Abstract][Full Text] [Related]
24. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
25. Detection of early breast cancer beyond mammographic screening: a promising biomarker panel.
Hamann M; Grill S; Struck J; Bergmann A; Hartmann O; Pölcher M; Kiechle M
Biomark Med; 2019 Sep; 13(13):1107-1117. PubMed ID: 31468986
[No Abstract] [Full Text] [Related]
26. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme--a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone.
Gilbert FJ; Tucker L; Gillan MG; Willsher P; Cooke J; Duncan KA; Michell MJ; Dobson HM; Lim YY; Purushothaman H; Strudley C; Astley SM; Morrish O; Young KC; Duffy SW
Health Technol Assess; 2015 Jan; 19(4):i-xxv, 1-136. PubMed ID: 25599513
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
29. Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.
Cho N; Han W; Han BK; Bae MS; Ko ES; Nam SJ; Chae EY; Lee JW; Kim SH; Kang BJ; Song BJ; Kim EK; Moon HJ; Kim SI; Kim SM; Kang E; Choi Y; Kim HH; Moon WK
JAMA Oncol; 2017 Nov; 3(11):1495-1502. PubMed ID: 28655029
[TBL] [Abstract][Full Text] [Related]
30. Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?
Bicchierai G; Amato F; Vanzi B; De Benedetto D; Boeri C; Vanzi E; Di Naro F; Bianchi S; Cirone D; Cozzi D; Miele V; Nori J
Breast; 2020 Dec; 54():15-24. PubMed ID: 32889303
[TBL] [Abstract][Full Text] [Related]
31. Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer.
Vyas A; Madhavan S; Sambamoorthi U
Breast Cancer Res Treat; 2014 Dec; 148(3):645-54. PubMed ID: 25399230
[TBL] [Abstract][Full Text] [Related]
32. Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort.
Buron A; Vernet M; Roman M; Checa MA; Pérez JM; Sala M; Comas M; Murta-Nascimiento C; Castells X; Macià F
Breast; 2013 Feb; 22(1):83-8. PubMed ID: 23141024
[TBL] [Abstract][Full Text] [Related]
33. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
34. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
[TBL] [Abstract][Full Text] [Related]
35. Mammography use and mode of detection among breast cancer patients in Estonia.
Innos K; Valvere V; Padrik P; Eelma E; Kütner R; Lehtsaar J; Tekkel M
Women Health; 2016; 56(2):129-40. PubMed ID: 26327255
[TBL] [Abstract][Full Text] [Related]
36. Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry.
Cheng F; Wang Z; Huang Y; Duan Y; Wang X
Clin Chim Acta; 2015 Jul; 447():23-31. PubMed ID: 25987308
[TBL] [Abstract][Full Text] [Related]
37. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA 21 and microRNA 10b: early diagnostic biomarkers of breast cancer in Egyptian females.
Ali M; El Gayar D; Hany N; Ezzat AH; Zeyada R
J Egypt Natl Canc Inst; 2022 Apr; 34(1):16. PubMed ID: 35399150
[TBL] [Abstract][Full Text] [Related]
39. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
40. Prospective validation of a blood-based 9-miRNA profile for early detection of breast cancer in a cohort of women examined by clinical mammography.
Lyng MB; Kodahl AR; Binder H; Ditzel HJ
Mol Oncol; 2016 Dec; 10(10):1621-1626. PubMed ID: 27839676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
